The Anti-Inflammatory Potential of Tricyclic Antidepressants (TCAs): A Novel Therapeutic Approach to Atherosclerosis Pathophysiology

Atherosclerosis, a chronic inflammatory disease, is driven by complex molecular mechanisms involving inflammatory cytokines and immune pathways. According to recent research, tricyclic antidepressants (TCAs), which are typically prescribed to treat depressive disorders, have strong anti-inflammatory...

Full description

Bibliographic Details

Published in:	Pharmaceuticals
Main Authors:	Majid Eslami, Marzieh Monemi, Mohammad Ali Nazari, Mohammad Hossein Azami, Parand Shariat Rad, Valentyn Oksenych, Ramtin Naderian
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Subjects:	tricyclic antidepressants (TCAs) atherosclerosis pathophysiology inflammasome cytokine
Online Access:	https://www.mdpi.com/1424-8247/18/2/197